Among several cancer antigens, mucin 1 (MUC1)—a type I transmembrane protein that plays role in mucous membrane protection, signal transduction, and modulation of immune system16, is one of the best potential target antigens for CAR T cell therapy because it is overexpressed in several cancers and its expression is related to cancer progression17. The gene discussed is MUC1; the disease is cancer.